CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

F. Markus Leweke - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

F. Markus Leweke

OPENALEX: A5073016358↗ORCID: 0000-0002-8163-195X↗

Affiliations

Organizations

Central Institute of Mental Healthauthorship · DE Heidelberg Universityauthorship · DE Heinrich Heine University Düsseldorfauthorship · DE Klinik und Poliklinik für Psychiatrie und Psychotherapieauthorship · DE Medizinische Hochschule Hannoverauthorship · DE The University of Sydneyauthorship · AU University Hospital Cologneauthorship · DE University Hospital Heidelbergauthorship · DE University of Cologneauthorship · DE

Public evidence

4 connected articles

Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers.2024 · Europe PMC Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density.2023 · Europe PMC Simultaneous Assessment of Serum Levels and Pharmacologic Effects of Cannabinoids on Endocannabinoids and <i>N</i>-Acylethanolamines by Liquid Chromatography-Tandem Mass Spectrometry.2023 · Europe PMC Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence.2016 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.